Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Statistics

Total Valuation

KRX:003060 has a market cap or net worth of KRW 124.87 billion. The enterprise value is 346.23 billion.

Market Cap	124.87B
Enterprise Value	346.23B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:003060 has 197.57 million shares outstanding. The number of shares has increased by 188.33% in one year.

Current Share Class	197.57M
Shares Outstanding	197.57M
Shares Change (YoY)	+188.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.09%
Float	84.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.83
PB Ratio	0.37
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.87
EV / Sales	5.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.08

Financial Position

The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.53.

Current Ratio	0.64
Quick Ratio	0.26
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	-3.16
Interest Coverage	-11.93

Financial Efficiency

Return on equity (ROE) is -50.77% and return on invested capital (ROIC) is -10.44%.

Return on Equity (ROE)	-50.77%
Return on Assets (ROA)	-9.26%
Return on Invested Capital (ROIC)	-10.44%
Return on Capital Employed (ROCE)	-22.01%
Revenue Per Employee	174.74M
Profits Per Employee	-474.17M
Employee Count	391
Asset Turnover	0.11
Inventory Turnover	1.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.55% in the last 52 weeks. The beta is 0.06, so KRX:003060's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-52.55%
50-Day Moving Average	629.84
200-Day Moving Average	729.81
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	502,334

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003060 had revenue of KRW 68.32 billion and -185.40 billion in losses. Loss per share was -969.88.

Revenue	68.32B
Gross Profit	-26.77B
Operating Income	-89.72B
Pretax Income	-185.44B
Net Income	-185.40B
EBITDA	-69.52B
EBIT	-89.72B
Loss Per Share	-969.88

Balance Sheet

The company has 29.18 billion in cash and 179.80 billion in debt, giving a net cash position of -150.62 billion or -762.34 per share.

Cash & Cash Equivalents	29.18B
Total Debt	179.80B
Net Cash	-150.62B
Net Cash Per Share	-762.34
Equity (Book Value)	338.48B
Book Value Per Share	1,355.12
Working Capital	-69.46B

Cash Flow

In the last 12 months, operating cash flow was -39.80 billion and capital expenditures -17.17 billion, giving a free cash flow of -56.97 billion.

Operating Cash Flow	-39.80B
Capital Expenditures	-17.17B
Free Cash Flow	-56.97B
FCF Per Share	-288.34

Margins

Gross margin is -39.18%, with operating and profit margins of -131.32% and -271.36%.

Gross Margin	-39.18%
Operating Margin	-131.32%
Pretax Margin	-271.41%
Profit Margin	-271.36%
EBITDA Margin	-101.74%
EBIT Margin	-131.32%
FCF Margin	n/a

Dividends & Yields

KRX:003060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-188.33%
Shareholder Yield	-188.33%
Earnings Yield	-148.48%
FCF Yield	-45.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 27, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 27, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

KRX:003060 has an Altman Z-Score of -0.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.96
Piotroski F-Score	1